NCT02831959Phase 3Completed

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Study sponsor: NovoCure GmbH

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-11-29Actual
Enrollment · participants298Actual
Source updated2025-10-31Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview